Exchange: NASDAQ·Updated 07:53 PM EDT

AMGN News

News
all
press releases
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
The latest trading day saw Amgen (AMGN) settling at $382.47, representing a -2.25% change from its previous close.
Zacks
More News
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAmgen delivers strong profitability and a diverse portfolio of established chronic disease treatments...
Nasdaq News: Markets
Biotech Whiplash: Big Pharma Setbacks Just Created a New Wave of Rebound Plays
The biotech tape delivered a brutal reminder of one of the sector’s oldest rules: a great company can get crushed by bad news somewhere else in the pipeline. A Novartis (NYSE:NVS) setback rippled through the biotech space, yesterday, dragging down companies whose own announcements were positive.
24-7 Market News
AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer Study
Amgen and AstraZeneca's Imdelltra-Imfinzi combo shows survival benefits in first-line ES-SCLC, potentially broadening both drugs' reach.
Zacks
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif., Sept. 9, 2026 THOUSAND OAKS, Calif., Sept. 9, 2026 /PRNewswire/ -- Amgen(NASDAQ:AMGN) will present at...
PR Newswire
Notable Tuesday Option Activity: AMGN, VST, DELL
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Amgen Inc (Symbol: AMGN), where a total volume of 24,919 contracts has been traded thus far today, a contract volume which is representative of approximately 2.5...
Nasdaq News: Markets
Stocks making the biggest moves midday: Amgen, Qualcomm, Expedia, CoreWeave & more
Here are some of the companies making headlines in midday trading...
CNBC: Top News
What's Going On With Amgen Stock Tuesday?
AMGN stock dips 9% after rival drug trial misses goal. Discover Amgen key support levels, technical outlook, and analyst price targetsread more...
Benzinga
This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Analysts downgraded BioNTech, Gulfport Energy, Amgen and Best Buy; price targets fell for BioNTech and Gulfport.read more...
Benzinga
IMDELLTRA IN COMBINATION WITH IMFINZI DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
IMDELLTRA IN COMBINATION WITH IMFINZI DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER IMDELLTRA IN COMBINATION WITH IMFINZI DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER PR...
PR Newswire

Advertisement|Remove ads.